'''This is a landscape report on the Ureteral stent market, including key company profiles, products, patents and relevant clinical trailstrials.
'''
=Patents=
==Patent Search Strategy==
[[Image:Patent Search Strategy.jpg|700px]]
'''Dashboard Link'''<br>
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|'''[httphttps://clientwww.dolcera.com/auth/dashboard/dashboard.htmlphp?workfile_id=1008 Ureteral Stent - Dashboard] '''
|width="100"|[[Image:dashboard_thumb.png|center|100px|]]
|-
= Clinical Trials =
==New trials ==
|}
=Products=
=Products=
The FDA classifies a ureteric stent as follows:
* TITLE 21 - FOOD AND DRUGS
|-
|}
= Product to Clinical Trial Mapping=
= Product to Patent Mapping =
[[Image:Product_Patent_Mapping_Screen_Shot.png|1000px|centre|thumb|'''Screenshot for the product to patent mapping(Bard and Boston)''']]
* Click [[Media:Product_Patent_Mapping_Bard_Boston.xls|'''Products from Boston Scientific and C R Bard ''']]to download the excel file.
=Patent-Product-Clinical Trial Mapping=
* To access the Dashboard you have to signup. You can do so by clicking [https://www.dolcera.com/auth/index.php/login '''here''']
*''Use the mouse(click and drag/scroll up or down/click on nodes) to explore nodes in the detailed taxonomy''
|}
=Insights=
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|bgcolor = "#538ED5"|<font size = "4">''' '''</font>
|bgcolor = "#538ED5"|<font size = "4">''' '''</font>
|bgcolor = "#538ED5"|<font size = "4">'''Boston Scientific'''</font>
|bgcolor = "#538ED5"|<font size = "4">'''C R BARD'''</font>
|-
|align = "center" bgcolor = "#538ED5" rowspan = "4"|'''Products'''
|'''Portfolio'''
|8 Products
|6 Products
|-
|'''Material'''
|Percuflex - Biocompatible Polymer
|Silicone
|-
|'''Coating'''
|Hydroplus
|Licensed from pHreecoat
|-
|'''Shape'''
|Pigtailed and More
|Figure 4 and more
|-
|align = "center" bgcolor = "#538ED5"|'''Clinical <br>Trials'''
|'''Current Trials'''
|Truimph Ureteral stent - Loaded with Triclosan <br>Currently in Phase II (Canada)
|None
|-
|align = "center" bgcolor = "#538ED5" rowspan = "3"|'''Patents'''
|'''Coating'''
|Therapeutic / Medicinal coatings <br>Magnetic nano particles for MRI Imaging <br>Lubricious coatings helping easy insertion
|Therapeutic coatings
|-
|'''Structure'''
|Multiple channels filled with therapeutic agent<br>Multiple collapsible segments preventing fluid passing<br>Renal coil with wick to prevent reflux <br>Stent with beads on its surface <br>Stent with reservoir indicating its release <br>with change in color of urine<br>Expandable and collapsible stent<br>Stents with degradable barbs
|Expandable stents for reducing discomfort
|-
|'''Material'''
|Elastically deformable stents<br>Biodegradable polymer based stents<br>Porous polymer for long term implantation<br>Stent with variable hardness
|Biodegradable polymers<br>Shape memory alloys<br>General polymer based
|-
|}
== Inference =Insights=
{|border="2" cellspacing="0" cellpadding="4" width="82%"
==IP Activity==
*Patenting activity has been high growth rate during the period 2001 to 2005 with a peak no. of patents in year 2005, followed by saturation during the period 2006 to 2008 and after that a gradual declination upto year 2010 in the ureteral stent research area.
[[Image:IPactivity3.png|thumb|center|1000px|year wise IP activityover the years]]
==Sales ==
Total Sales in 2010 - 4.04 Billion USD
All figures in USD million [[image:stentshare.jpg]] ====Boston Scientific==== [https://dolcera.net/teamwiki_prod/index.php/Boston_Scientific_-_Company_Profile Company profile] [http://www.bostonscientific.com/templatedata/imports/Microsite/Stone/collateral/Percuflex-Brochure.pdf Ureteral Stent portfolio] Net sales |thumb|center|1000px| All figures in 2010 – USD 7.8 Billion Share of Urology- 8.48 % Net sales from Urology- USD 661 Million Source [http://phx.corporate-ir.net/phoenix.zhtml?c=62272&p=irol-reportsother BSsalesdatamillion ] ====CR BARD==== [[Urology portfolio]] Net sales in 2010 – USD 2.7 Billion Share of Urology- 26% Net sales from Urology- USD 702 Million Source – CR BARD annual report ====Cook Medical==== [http://www.cookmedical.com/uro/familyListingAction.do?family=Ureteral+Stents Ureteral Stent portfolio] Total Sales - USD 1.7 Billion [http://www.nytimes.com/2011/04/26/business/26cook.html?_r=1 Source] ====Medline==== [http://www.medline.com/irj/catalog/search?initialSearchTerms=ureteral%20stent Ureteral Stent Portfolio]
=<span style="color:#C41E3A">Like this report?</span>=